Inactive Instrument
LungLife AI, Inc. Stock
Stocks
LLAI
USU5500L1045
Biotechnology & Medical Research
| 1 day | -2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Pagano
CEO | Chief Executive Officer | 42 | - |
David Anderson
DFI | Director of Finance/CFO | 63 | - |
Michael Donovan
CTO | Chief Tech/Sci/R&D Officer | 72 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sara Barrington
BRD | Director/Board Member | 59 | 2021-07-07 |
David Anderson
BRD | Director/Board Member | 63 | 2021-07-07 |
Paul Pagano
BRD | Director/Board Member | 42 | 2020-05-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/4/24 | Free | Chief Executive Officer | 769,707 | 3.0201% | ||
| 10/4/24 | Free | Chief Financial Officer | 386,703 | 1.5173% | ||
| 8/14/23 | Buy | Chief Executive Officer | 12,123 | 0.0476% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.35% | +18.57% | - | - | 1.7M | |
| -3.10% | -3.43% | +36.29% | +67.69% | 65.28B | |
| +0.33% | +7.26% | +11.51% | +77.95% | 54.57B | |
| +0.16% | +3.69% | +8.39% | +101.27% | 53.59B | |
| -0.75% | +2.13% | +23.14% | +47.25% | 45.03B | |
| -1.30% | -1.11% | +17.77% | +120.71% | 42.17B | |
| +1.26% | +2.23% | +241.81% | +835.31% | 39.42B | |
| -0.74% | -4.84% | +14.53% | +44.45% | 32.71B | |
| -2.70% | -7.34% | +23.17% | +0.36% | 24.01B | |
| +1.11% | +17.90% | +56.87% | +47.78% | 26.5B | |
| Average | -0.81% | +1.98% | +48.16% | +149.20% | 42.59B | |
| Weighted average by Cap. | -0.72% | +1.72% | +45.16% | +148.64% |
Employees
8
